A

Aditxt
D

ADTX

0.092000
USD
-0.02
(-20.48%)
مغلق
حجم التداول
10,076,997
الربح لكل سهم
-92
العائد الربحي
-
P/E
0
حجم السوق
7,258,130
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ADCT
    -0.04000
    (-2.40%)
    1.63000 USD
    A
    ALT
    -0.19000
    (-2.87%)
    6.42000 USD
    A
    APT
    0.10000
    (1.82%)
    5.60000 USD
    C
    CDTX
    -0.990
    (-4.42%)
    21.430 USD
    C
    CODX
    0.01720
    (2.46%)
    0.71700 USD
    N
    NVAX
    0.05500
    (0.69%)
    7.98000 USD
    V
    VIR
    -0.22000
    (-2.24%)
    9.58000 USD
    V
    VXRT
    0.00670
    (0.95%)
    0.70980 USD
    المزيد
الأخبار
المقالات

العنوان: Aditxt Inc

القطاع: Healthcare
الصناعة: Biotechnology
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics the way bodies naturally induce tolerance to tissues.